Simple non-invasive fibrosis scores identify patients with non-alcoholic fatty liver disease who progress to advanced fibrosis/cirrhosis:evidence from a large cohort of patients with sequential liver biopsies

Temporal assessment of the non-invasive fibrosis scores Fib-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score (Nfs) in a retrospective cohort study among patients with Non-Alcoholic Fatty Liver Disease (Nafld). Journal of Hepatology 68: S565-S566, 2018

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 59(9): 1265-1269, 2010

Simple Non Invasive Fibrosis Scores Predict Long Term Mortality in Patients with Non Alcoholic Fatty Liver Disease. Journal of Hepatology 64(2): S720-S721, 2016

AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. Digestive and Liver Disease 49(10): 1133-1138, 2017

Tu1036 The Cirrhosis Risk Score is Not Associated With Liver Fibrosis/Cirrhosis and Fibrosis Progression in Chinese Non-Alcoholic Fatty Liver Disease Patients. Gastroenterology 142(5): S-1017, 2012

Primary Care Sequential Use of FIB-4 and the Enhanced Liver Fibrosis Test to Stratify Patients with Non-alcoholic Fatty Liver Acide Doubles Cirrhosis Detection and Reduces Referrals of Patients with Mild Disease. Journal of Hepatology 64(2): S474-S475, 2016

Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis. Clinical Gastroenterology and Hepatology 2019, 2019

Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease. Gastroenterology Report 2(4): 276-280, 2014

T1011 Independent Predictors of Fibrosis in a Large Cohort of Patients with Non-Alcoholic Fatty Liver Disease. Gastroenterology 136(5): A-846, 2009

Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver International 36(4): 572-579, 2016

How do non-invasive fibrosis scoring systems compare with transient elastography in the diagnosis of fibrosis in patients with non alcoholic fatty liver disease. Gut 60(Suppl 1): A225-A226, 2011

Validation of the "NAFLD fibrosis score" in predicting advanced fibrosis in patients with histologically proven non-alcoholic fatty liver disease. 2007

Non invasive diagnostic modalities to predict advanced hepatic fibrosis in patients with non alcoholic fatty liver disease: a retrospective study. Journal of Hepatology 66(1): S658-S659, 2017

Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis. Journal of Gastroenterology and Hepatology 32(5): 950-956, 2016

Low skeletal muscle mass is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2019, 2019